Medicinova (MNOV) Financials

$1.87

$0.06 (3.31%)

As on 14-Sep-2026 16:00EDT

Market cap

$89 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.92	0.41	--	1.00	--	4.04
Cost of Revenue	0.53	0.38	0.02	0.02	0.21	--
Gross Profit	0.39	0.03	-0.02	1.00	-0.21	4.04
Operating Expenses	12.24	13.31	12.68	10.90	14.63	14.25
Operating Profit (EBIT)	-11.85	-13.28	-12.68	-9.90	-14.63	-10.22
Other Income	--	--	--	--	0.56	0.08
Profit before Tax	-10.75	-11.99	-11.04	-8.57	-14.07	-10.13
Provision for Tax	0.01	0.01	0.01	0.00	0.00	0.00
Profit after Tax (Net Income)	-10.75	-12.00	-11.05	-8.57	-14.07	-10.13
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.07	-10.13

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	37.27	41.59	52.50	62.38	70.24	83.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.20	0.22	0.41	0.61	0.73	0.90
Current Liabilities	2.96	3.80	2.96	3.28	3.19	2.83
Total Liabilities	43.39	45.60	55.88	66.27	74.15	87.41

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	14.51	14.61	14.80	15.10	15.17	15.40
Current Assets	25.92	30.99	41.07	51.17	58.99	72.01
Total Assets	43.39	45.60	55.88	66.27	74.15	87.41
Total Debt*	0.12	0.19	0.19	0.22	0.68	0.83
Net Current Assets	22.96	27.19	38.12	47.90	55.80	69.18

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.81	-10.64	-7.43	-12.91	-9.38
Cash Flow from Investing Activities	--	0.00	0.00	39.91	-40.01	-0.03
Cash from Financing Activities	--	0.24	--	32,461.46	0.01	20.78
Net Cash Inflow / Outflow	--	--	--	--	-52.91	11.37

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.22	-0.24	-0.23	-0.17	-0.29	-0.21
Cash EPS ($)	-0.22	-0.24	-0.22	-0.17	-0.29	-0.21
Adjusted Book Value ($)	0.76	0.85	1.07	1.27	1.43	1.71
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.20	-0.22	-0.15	-0.26	-0.19
Free Cash Flow per Share ($)	--	-0.20	-0.22	-0.15	-0.26	-0.19

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-25.40	-19.17	-12.84	-18.10	-12.99
ROE (%)	-27.27	-25.50	-19.24	-12.93	-18.28	-13.08
ROA (%)	-22.43	-23.65	-18.09	-12.21	-17.42	-12.45
EBIT Margin (%)	-916.14	-2,927.32	--	-856.85	--	-250.94
Net Margin (%)	-1,168.20	-2,928.78	--	-857.15	-2,501.67	-245.88
Cash Profit Margin (%)	-0.06	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	583.87	--	-1.00	--	-1.00	0.01
EBIT Growth (%)	28.57	-8.58	-28.89	39.08	-38.83	28.54
Net Profit Growth (%)	8.97	-8.58	-28.91	39.08	-38.83	26.85
EPS Growth (%)	9.12	-0.09	-0.29	0.39	-0.39	0.33
Book Value Growth (%)	-20.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.36	-9.32	-8.58	-7.15	-12.95
Price / Book Value	2.28	1.55	1.96	1.18	1.43	1.57
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.65	-2.81	-5.70	-2.67	-3.04	-6.00
Close Price ($)	1.32	1.31	2.10	1.50	2.05	2.68
High Price ($)	1.96	2.20	2.55	2.66	3.18	10.81
Low Price ($)	1.17	1.13	1.12	1.38	1.95	2.57
Market Cap ($ Cr)	89.09	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.00	0.01	0.01
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	8.75	8.16	13.88	15.61	18.51	25.42
Quick Ratio	8.75	--	--	--	--	--
Interest Coverage	--	--	--	--	-25.01	-120.43

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.02	0.01	--	0.01	--	0.05
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	833.27	18,251.50	12,855.14	711.31	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.